Literature DB >> 8643625

Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42.

R Kolluri1, K F Tolias, C L Carpenter, F S Rosen, T Kirchhausen.   

Abstract

Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency disorder with the most severe pathology in the T lymphocytes and platelets. The disease arises from mutations in the gene encoding the WAS protein. T lymphocytes of affected males with WAS exhibit a severe disturbance of the actin cytoskeleton, suggesting that the WAS protein could regulate its organization. We show here that WAS protein interacts with a member of the Rho family of GTPases, Cdc42. This interaction, which is guanosine 5'-triphosphate (GTP)-dependent, was detected in cell lysates, in transient transfections and with purified recombinant proteins. A weaker interaction was also detected with Rac1 using WAS protein from cell lysates. It was also found that different mutant WAS proteins from three affected males retained their ability to interact with Cdc42 and that the level of expression of the WAS protein in these mutants was only 2-5% of normal. Taken together these data suggest that the WAS protein might function as a signal transduction adaptor downstream of Cdc42, and in affected males, the cytoskeletal abnormalities may result from a defect in Cdc42 signaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8643625      PMCID: PMC39296          DOI: 10.1073/pnas.93.11.5615

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Eczema associated with thrombocytopenic purpura and purulent otitis media; report of five fatal cases.

Authors:  C C HUNTLEY; S C DEES
Journal:  Pediatrics       Date:  1957-03       Impact factor: 7.124

2.  Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea.

Authors:  R A ALDRICH; A G STEINBERG; D C CAMPBELL
Journal:  Pediatrics       Date:  1954-02       Impact factor: 7.124

Review 3.  Cell biology of cytotoxic and helper T cell functions: immunofluorescence microscopic studies of single cells and cell couples.

Authors:  A Kupfer; S J Singer
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

4.  Wiskott-Aldrich syndrome. An immunologic deficiency disease involving the afferent limb of immunity.

Authors:  M D Cooper; H P Chae; J T Lowman; W Krivit; R A Good
Journal:  Am J Med       Date:  1968-04       Impact factor: 4.965

5.  Dichotomy of antibody response to group A streptococcal antigens in Wiskott-Aldrich syndrome.

Authors:  E M Ayoub; B A Dudding; M D Cooper
Journal:  J Lab Clin Med       Date:  1968-12

6.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets.

Authors:  H D Ochs; S J Slichter; L A Harker; W E Von Behrens; R A Clark; R J Wedgwood
Journal:  Blood       Date:  1980-02       Impact factor: 22.113

7.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

8.  Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome.

Authors:  P Aspenström; U Lindberg; A Hall
Journal:  Curr Biol       Date:  1996-01-01       Impact factor: 10.834

9.  Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome.

Authors:  D Kenney; L Cairns; E Remold-O'Donnell; J Peterson; F S Rosen; R Parkman
Journal:  Blood       Date:  1986-12       Impact factor: 22.113

10.  Spatial relationships of microtubule-organizing centers and the contact area of cytotoxic T lymphocytes and target cells.

Authors:  B Geiger; D Rosen; G Berke
Journal:  J Cell Biol       Date:  1982-10       Impact factor: 10.539

View more
  43 in total

Review 1.  Learning from the slime mold: Dictyostelium and human disease.

Authors:  C L Saxe
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

Review 2.  CD43, a molecule with multiple functions.

Authors:  Y Rosenstein; A Santana; G Pedraza-Alva
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 3.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

Review 4.  The Wiskott-Aldrich syndrome.

Authors:  A J Thrasher; C Kinnon
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 5.  Rho GTPases and their effector proteins.

Authors:  A L Bishop; A Hall
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

6.  A WASp-VASP complex regulates actin polymerization at the plasma membrane.

Authors:  F Castellano; C Le Clainche; D Patin; M F Carlier; P Chavrier
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

7.  Mutational analysis of the WASP gene in 2 Korean families with Wiskott-Aldrich syndrome.

Authors:  Eun-Kyeong Jo; Takeshi Futatani; Hirokazu Kanegane; Takeo Kubota; Young-Ho Lee; Jin-A Jung; Chang-Hwa Song; Jeong-Kyu Park; Shigeaki Nonoyama; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

Review 8.  The Wiskott-Aldrich syndrome.

Authors:  H D Ochs
Journal:  Springer Semin Immunopathol       Date:  1998

9.  NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma.

Authors:  C A Murga-Zamalloa; V Mendoza-Reinoso; A A Sahasrabuddhe; D Rolland; S R Hwang; S R P McDonnell; A P Sciallis; R A Wilcox; V Bashur; K Elenitoba-Johnson; M S Lim
Journal:  Oncogene       Date:  2016-10-03       Impact factor: 9.867

10.  N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer.

Authors:  Tracey A Martin; Gordon Pereira; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2007-11-06       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.